Feedback Message Board

Global Presence. Export More than 70 Country. Year to Year Revenue Growth Positive. FY 2020-21 630+ Cr., FY 2021-22 736+ Cr. & FY 2022-23 888+ Cr & Profit Growth is Positive FY 2020-21 235 Cr, FY 2022-23 240+ Cr. & Main Positive side of Concord Biotech, Company Borrowing is Reduce year to year. Total Borrowing FY 2020-21 Rs. 86.35 Cr., FY 2021-22       Rs. 60.59 Cr. & FY 2022-23 Rs. 31.24 Cr. Very Positive.

Superb Company. Global Presence. Company has Immunosuppressant (Tacrolimus, Mycophenolate Mofetil) Medicine World Market Share up to Approx 80 to 85 present. World Market Leader for Immunosuppressant Medicine. Company has Own Research Center. Dholka Plant facility is spread over 596,309 square meters & Valthera, Ahmedabad Plant is spread over 94,826 square meters.